Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThis change updates the ClinicalTrials.gov page’s UI/release revision marker from v3.5.2 to v3.5.3 without altering the displayed study details.SummaryDifference0.1%

- Check22 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No study content or user-facing information appears to have changed.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the revision history.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision tag updated to v3.4.3. The previous v3.4.2 tag was removed.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.4.2; Deleted older notice about funding/operation status (Revision: v3.4.1). These are administrative updates that do not affect trial content or how users interact with the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.